| Name | Title | Contact Details |
|---|---|---|
Patrick Schiess |
Chief Technology Officer | Profile |
Blueprint Medicines is developing a new generation of highly selective and potent kinase therapies to dramatically improve the lives of patients with genomically defined diseases. Our approach is rooted in a deep understanding of the genetic blueprint of cancer and other diseases driven by the abnormal activation of kinases. Our ability to identify novel drivers of disease, coupled with our proprietary library of novel and diverse chemical compounds, uniquely enables us to craft kinase therapies against new and difficult-to-drug targets. We are boldly advancing a deep pipeline of highly targeted therapies against previously unaddressed drivers of disease. By focusing on genomically defined subsets of patients, we believe we can identify the people most likely to respond to our therapies, resulting in a more efficient clinical development path with a greater likelihood of success and better outcomes for patients. We see a substantial opportunity in kinase drug discovery and development to deliver breakthrough medicines that allow patients to live longer with better quality of life and prevent recurrences of disease. Kinases are involved in many hallmarks of tumor biology and are proven cancer drug targets. Currently approved drugs focus on less than 5 percent of known kinases, and the function of most kinases is unknown. Led by a team of industry innovators with a track record of bringing life-changing drugs to market, we believe Blueprint Medicines has the experience and expertise to deliver on the tremendous untapped potential of kinase therapies to improve patients’ lives. We don’t think in small steps. We think in giant leaps. We are driven by the pursuit of new ideas, new innovations, and new ways of thinking.
More than 65 academic medical centers use ARUP as their primary reference laboratory and ARUP also provides all laboratory services, including phlebotomy and support services, for the 490-bed University of Utah Hospitals and Clinics. ARUP's 1,700
Brit-Tex Nursing Service Inc is a San Antonio, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Founded by Dr. Samuel Brown, Brown Fertility is a fully comprehensive fertility clinic offering patients exceptional results through personalized care and affordable treatment plans. With over 15 years experience and the management of more than 5,000 IVF cycles, Dr. Samuel Brown consistently achieves success rates above the national average. From basic evaluation and testing to the most advanced procedures and treatments available, Brown Fertility is dedicated to Conceiving Miracles™.
MusclePharm is an award winning and worldwide leading sports nutrition brand. Our expansive line of clinically proven safe and effective supplements reaches all elements of the active, push-the-edge lifestyle—from muscle building, athletic performance, weight loss and general fitness.